Education, Science, Technology, Innovation and Life
Open Access
Sign In

Mechanisms and Treatment Strategies of Motor Complications in Parkinson's Disease Patients

Download as PDF

DOI: 10.23977/medsc.2025.060402 | Downloads: 6 | Views: 117

Author(s)

Jiaoyang Yan 1

Affiliation(s)

1 The Fifth Clinical Medical College, Xinjiang Medical University, Urumqi, 830054, China

Corresponding Author

Jiaoyang Yan

ABSTRACT

The sports complications of Parkinson's disease (PD) seriously affect the quality of life of patients. This article discusses its related contents in depth. This article expounds the pathogenesis of sports complications in neurotransmitter imbalance, neuroplasticity changes, genes and genetic factors and other related factors (age, course of disease, severity of disease, brain inflammation, oxidative stress, etc.). In terms of treatment strategy, drug therapy includes adjusting the dosage, dosage form and frequency of administration of existing drugs such as levodopa, combined application of dopamine receptor agonists, monoamine oxidase -B inhibitors, and auxiliary drugs such as COMT inhibitors, while paying attention to the research and development progress of new drugs. Surgical treatment includes deep brain stimulation (DBS) and other operations such as nucleus destruction, emerging stem cell transplantation and gene therapy. Rehabilitation treatment covers physics, homework, speech therapy and so on. Various treatment strategies have their own characteristics and limitations, and multi-pronged approach is expected to improve the status of patients with PD motor complications.

KEYWORDS

Parkinson's Disease; Sports Complications; Treatment Strategy; Drug Therapy; Surgical Treatment

CITE THIS PAPER

Jiaoyang Yan, Mechanisms and Treatment Strategies of Motor Complications in Parkinson's Disease Patients. MEDS Clinical Medicine (2025) Vol. 6: 7-11. DOI: http://dx.doi.org/10.23977/medsc.2025.060402.

REFERENCES

[1] Santos-Lobato B L, Brito M M C M, Pimentel  V, et al. Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study[J]. Arquivos de Neuro-Psiquiatria, 2023, 81(05): 460-468.
[2] Spanaki C, Boura I, Avgoustaki A, et al. Buried bumper syndrome: a common complication of levodopa intestinal infusion for Parkinson disease[J]. Parkinsonism & Related Disorders, 2021, 85: 59-62.
[3] Stamenovi J, Ivadinovi B, Uri V. Clinical characteristics and treatment of psychosis in Parkinson's disease: A narrative review[J]. Journal of the Chinese Medical Association, 2024, 87(11):972-979.
[4] Astalosch M, Mousavi M, Ribeiro L M, et al. Risk Factors for Postoperative Delirium Severity After Deep Brain Stimulation Surgery in Parkinson’s Disease[J]. Journal of Parkinson’s Disease, 2024, 14(6): 1175-1192.
[5] Li H, Yang Y, Yang L,et al.Clinical management model for impulse control disorders in Parkinson's disease[J].CNS Spectrums, 2024, 29(5):306-315.
[6] Yousef O, Abouelmagd M E, Abbas A, et al. Delirium after deep brain stimulation for Parkinson's disease: a meta-analysis of incidence and risk factors[J]. Neurosurgical Review, 2025, 48(1): 1-13.
[7] Gupta H V, Lenka A, Dhamija R K, et al. A video-atlas of levodopa-induced dyskinesia in Parkinson's disease: terminology matters[J]. Neurological Sciences, 2024, 45(4): 1389-1397.
[8] Mamaril‐Davis J C, Gelb A W, Larson P S. Procedure‐Related Complications in Sham Surgeries for Parkinson's Clinical Trials: A Meta‐analysis[J]. Movement Disorders, 2023, 38(7): 1223-1235.
[9] Servello D, Galbiati T F, Iess G, et al. Complications of deep brain stimulation in Parkinson's disease: a single-center experience of 517 consecutive cases[J]. Acta Neurochirurgica, 2023, 165(11): 3385-3396.
[10] Hinkle J T, Perepezko K, Mills K A, et al. Attentional dysfunction and the punding spectrum in Parkinson's disease[J]. Parkinsonism & related disorders, 2021, 84: 23-28.

Downloads: 9214
Visits: 555894

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.